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 Abstract 
 Background: After hypertensive disorders of pregnancy, more subjective cognitive com-
plaints and white matter lesions are reported compared to women after normal pregnancies. 
Both have a causal relationship with Alzheimer’s disease (AD).  Aim: To investigate if women 
whose pregnancy was complicated by hypertensive disorders have an increased risk of AD. 
 Methods: A case-control study in women with AD from the Alzheimer Center of the VU Uni-
versity Medical Center Amsterdam and women without AD. Paper and telephone surveys were 
performed.  Results: The response rate was 85.2%. No relation between women with (n = 104) 
and without AD (n = 129) reporting pregnancies complicated by hypertensive disorders (p = 
0.11) was found. Women with early-onset AD reported hypertensive disorders of pregnancy 
more often (p = 0.02) compared to women with late-onset AD.  Conclusion: A reported his-
tory of hypertensive disorders of pregnancy appears not to be associated with AD later in life. 
 © 2015 S. Karger AG, Basel 
 Introduction 
 Hypertensive disorders of pregnancy are a major cause of maternal and fetal morbidity 
and mortality  [1–4] and the most common disorders in pregnancy; their prevalence is almost 
10%  [2, 5, 6] . Hypertensive disorders of pregnancy is an umbrella term including preeclampsia 
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(systolic blood pressure  ≥ 140 mm Hg and/or diastolic blood pressure  ≥ 90 mm Hg and 
proteinuria  ≥ 300 mg/24 h), pregnancy-induced hypertension (hypertension as defined in 
preeclampsia, without proteinuria), eclampsia and elevated liver enzymes and low platelets 
(HELLP) syndrome. Despite extensive research, the exact causes of hypertensive disorders of 
pregnancy are still unknown. The main hypothesis is related to disturbed placental function 
in early pregnancy  [7] . As a consequence, generalized endothelial dysfunction develops, 
through which preeclampsia potentially affects the perfusion of several organs including 
liver, kidneys and brain  [7] . 
 Until recently, the pathophysiological and clinical effects of hypertensive disorders of 
pregnancy, including cardiovascular and cerebrovascular dysfunction, were thought to be 
reversible. However, increasing evidence points out that hypertensive disorders of preg-
nancy are associated with long-term effects on women’s health, e.g. increased risk of cardio-
vascular and cerebrovascular disease later in life  [8–21] .
 Long-term effects on cerebrovascular disease after a pregnancy complicated by (pre)ec-
lampsia have been observed, including a higher prevalence of subjective cognitive com-
plaints such as memory, attention and concentration deficits after several years, compared to 
women with a history of pregnancies without hypertension  [15–18] . Neuroimaging studies 
show evidence of long-term effects of (pre)eclampsia on the brain, including more frequent 
and larger cerebral white matter lesions compared to women who have had an uncompli-
cated pregnancy  [19–21] .
 The clinical implications of the presence and larger volume of white matter lesions in 
relatively young women remains unclear  [17, 22] . In elderly patients, white matter lesions 
have been described and linked to subjective cognitive complaints and Alzheimer’s disease 
(AD) pathology  [23–28] . Subjective cognitive complaints can be the first sign of AD in elderly 
whose objective cognitive performance is normal  [29] . Furthermore, white matter lesions on 
cerebral magnetic resonance imaging (MRI) correlate with subjective cognitive failure  [30] , 
and the severity of white matter lesions has been shown to predict the rate of cognitive decline 
over time  [31, 32] . These white matter lesions are suggested to play an important role in the 
pathogenesis of dementia  [33–35] . The frequency of white matter lesions in women with AD 
varies  [32, 36] . Although the etiology of AD is still not completely elucidated, it is now known 
that the presence of cerebral white matter lesions, vascular risk factors and endothelial 
dysfunction contribute to its development  [37–40] . 
 Based on the above-described association between hypertensive disorders of pregnancy 
and white matter lesions, and white matter lesions and AD, we hypothesize that women who 
have had a pregnancy complicated by hypertensive disorders are at increased risk of AD in 
later life. 
 Materials and Methods 
 Our study was a retrospective case-control study, in which we compared the reported 
prevalence of hypertensive disorders of pregnancy between women with AD and women 
without AD.
 Participants 
 We identified women with AD from the database of the Alzheimer Center of the VU 
University Medical Center in Amsterdam. All women had previously given written consent to 
participate in scientific research. For the control group, we selected partners of male AD 
patients who gave their consent for participating in scientific research. 
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 Participants were included when they had at least one pregnancy continuing after 24 
weeks’ gestation. Women were excluded when they had a history of other types of neurode-
generative diseases, thromboembolisms, systemic lupus erythematosus or diabetes prior to 
their first pregnancy, or when nulliparous. Also, women with other forms of dementia like 
vascular dementia and mild cognitive impairment were excluded. The Medical Ethical 
Committee of the VU University Medical Center approved the study. 
 Surveys 
 We used self-report methods to gather data concerning obstetric complications. Recall of 
hypertensive disorders of pregnancy is adequate (up to 30 years after the event) according 
to a systematic review which was conducted to comprehensively review and assess the 
available literature on maternal recall of hypertensive disorders of pregnancy, so we hypoth-
esized that recall, even in AD patients, would be sufficiently reliable  [41] .
 Initially, we sent all our participants a paper survey for assessment. We used a question-
naire including items about demographic background, lifestyle, medical history and obstetric 
history  [42] . The obstetric history items included the date of birth, number of pregnancies, 
parity, live births and stillbirths. Also, items concerning obstetric complications, i.e. hyper-
tension, low-salt diet, proteinuria, toxemia (previous term for preeclampsia) or preeclampsia 
and seizures or eclampsia, were included. Since we expected that women would not remember 
their lab results in pregnancy, we did not specifically ask if they had HELLP syndrome in 
history. Age at AD diagnosis was collected from the database of the Alzheimer Center. 
Secondary to the initial paper survey, we performed a telephone survey in nonresponders to 
achieve an optimal response rate and prevent response bias. In both paper and telephone 
surveys, partners or family members were allowed to support the participants to help 
complete the surveys, to gather as much information as possible.
 Cerebral MRI 
 In women with AD and a reported history of hypertensive disorders of pregnancy, we 
performed file searches and described their cerebral MRI scans. MRIs were acquired on a 
3-tesla whole-body MR system (MR750, GE Medical Systems, Milwaukee, Wis., USA; Ingenuity 
TF PET/MR, Philips Medical Systems, Best, The Netherlands; Titan, Toshiba Medical Systems, 
Japan). The standard MRI protocol included a sagittal 3-D heavily T1-weighted gradient-echo 
sequence with coronal reformats, a sagittal 3-D T2-weighted fluid-attenuated inversion 
recovery turbo/fast spin echo with axial reformats, a transverse T2-weighted turbo/fast spin 
echo and a transverse T2 * susceptibility sequence. All sequences were performed with whole-
brain coverage. 
 An experienced neuroradiologist reviewed all the scans. Temporal lobe atrophy (MTA) 
was scored from 0 to 4 (score 0, no atrophy; score 1, only widening of choroid fissure; score 
2, also widening of temporal horn of lateral ventricle; score 3, moderate loss of hippocampal 
volume (decrease in height); score 4, severe volume loss of the hippocampus). Global cortical 
atrophy (GCA) was scored from 0 to 3 (0, no cortical atrophy; 1, mild atrophy: opening of sulci; 
2, moderate atrophy: volume loss of gyri; 3, severe (end-stage) atrophy: ‘knife blade’ atrophy).
 White matter hyperintensities were rated using the Fazekas score and classified as punc-
tuate (grade 1), beginning confluent (grade 2) or confluent (grade 3)  [30] . The number of 
microbleeds was counted on T2 * sequences; they were defined as small round foci of hypoin-
tense signal, up to 10 mm in brain parenchyma  [31] . The numbers of infarctions were also 
counted. 
 Inter- and intrarater weighted kappas of at least 0.80 for MTA, 0.60 for GCA and 0.70 for 
Fazekas (against internally established gold standard) were required  [32] . For microbleed 
count, weighted Cohen’s kappas are >0.90  [31, 32] .
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 Sample Size Considerations and Statistical Analysis 
 In the general Dutch population, the prevalence of hypertensive disorders of pregnancy 
is 8.48% (Dutch Perinatal Registry). We expected to find a prevalence of hypertensive 
disorders of pregnancy twice as high in women with AD compared to women without AD. 
Since we are, to our knowledge, the first to describe a possible relation between AD and 
hypertensive disorders of pregnancy, we based our power calculation on a study that inves-
tigated a 30-year cardiovascular disease risk prediction by the Framingham risk score  [8] . 
They found an almost threefold higher risk for cardiovascular disease in women after hyper-
tensive disorders of pregnancy compared to women with a normotensive pregnancy. We 
made a conservative estimation by estimating the risk for AD twice as high in women with a 
history of hypertensive disorders. To achieve sufficient statistical power with an alpha of 0.05 
and a beta of 0.84, a required minimum of 233 participants per group was needed (double-
sided test).
 To analyze baseline characteristics, the parametric Student’s t test, χ 2 test, nonpara-
metric Mann-Whitney U test or Fisher’s exact tests were used. The χ 2 test was used to compare 
the presence of a reported history of hypertensive disorder of pregnancy, preeclampsia, 
eclampsia or pregnancy-induced hypertension between women with and without AD. The χ 2 
test was also used to compare the presence of a reported history of hypertensive disorder of 
pregnancy, preeclampsia, eclampsia or pregnancy-induced hypertension between women 
with early-onset AD (<65 years at the moment of diagnosis) or late-onset AD (>65 years at 
the moment of diagnosis). When appropriate, we conducted multiple logistic regression 
analyses to correct for potential confounders. Statistical analyses were performed with IBM 
SPSS 22.0 (SPSS Inc., Chicago, Ill., USA). Results were considered significant at the 5% level.
 Results 
 In total, 500 women were identified from the database of the Alzheimer Center of the VU 
University Medical Center; 251 women with AD and 249 women with a partner with AD. The 
overall response rate was 85.2%, 201 women with AD and 225 women without AD, consisting 
of 102 women responding to paper surveys in each group (40.6 and 40.9%, respectively), and 
99 (39.4%) women with AD and 123 (49.4%) women without AD responding to telephone 
survey. Of these 426 women, we excluded 169 women: 28 women due to nulliparity, 16 
women due to diagnoses of dementia different from AD (e.g. vascular dementia or mild 
cognitive impairment), 32 women were not willing or able to participate in the study (e.g. 
they could not answer the questions themselves anymore, carers did not have the time for it), 
9 women were deceased, 57 participants gave incomplete responses, 9 men had no (female) 
partner, and finally 18 women were nonresponders due to other reasons (e.g. they had a new 
partner who did not know anything about the pregnancies of his wife). As described in  figure 
1 , a total of 257 women were analyzed, 118 women with AD and 139 without. Of the women 
with AD, 43.2% were diagnosed with early-onset AD. Thirty-one women with AD (26.5%) and 
132 (95.7%) without AD answered the survey themselves. In 2 paper surveys (1 woman with 
and 1 without AD), the reporter was unclear. The mean time interval between the birth of the 
first child and the survey was 41.2 years for women with AD and 39.2 years for women 
without AD (p = 0.12). 
 The baseline characteristics are depicted in  table 1 . Women with AD were significantly 
older (p = 0.035) and had a lower body mass index (BMI) when they completed the survey 
than women without AD (p = 0.014). Three women (with AD) reported both preeclampsia 
and pregnancy-induced hypertension in their history. In these cases, we classified the women 
with a history of preeclampsia and not with pregnancy-induced hypertension to prevent 
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overestimation of hypertensive disorders of pregnancy. Neither mean birth weight (3,502 vs. 
3,399 g) nor gestational age of the firstborn differed between both groups (p = 0.30 and p = 
0.98, respectively).
 AD in Relation to Hypertensive Disorders of Pregnancy 
 There was no difference between the number of women with AD reporting pregnancies 
complicated by hypertensive disorders and the number of women without AD (12.7 vs. 
25.9%, p = 0.11 after correction for maternal age and BMI;  table 2 ). We detected no significant 
difference in reported histories of preeclampsia between women diagnosed with AD and 
those without AD (3.4 vs. 2.9%, p = 1.00 after correction for age and BMI;  table 2 ). In both 
groups, none of the women reported eclampsia. 
 Women with AD reported pregnancy-induced hypertension less often than women 
without AD (9.3 vs. 23.0%, p = 0.03 after correction for age and BMI). When differentiating 
between women with early-onset AD and late-onset AD, 10 women (20.4%) with early-onset 
AD and 3 women (5.2%) with late-onset AD reported a history of hypertensive disorders of 
pregnancy (p = 0.02). Three women with AD who reported a history of preeclampsia had 
early-onset AD; no women with late-onset AD reported a history of preeclampsia (p = 0.03). 
Regarding the 4th woman, it is unknown if she had early-onset or late-onset AD.
 We checked for report bias when comparing the rates of reported hypertensive disorders 
between self-reporting participants and rates reported by family members. Participants who 
did a self-report reported 16.1% (women with AD) and 25.8% (women without AD) rates of 
hypertensive disorders of pregnancy. Family members reported comparable rates of hyper-
tensive disorders of pregnancy: 11.6% in women with AD and 33.3% in women without AD.
Nonresponder on
paper survey
(n = 147)
Women without AD (n = 249)
Eligible women (n = 500)
Total response women without AD
(n = 225)
139 women without AD (controls)
analyzed
Excluded (n = 86)
10 nulliparous, 24 withdrawals,
5 deceased, 6 no specified reasons,
9 no partner, 32 missing data
Responder on
paper survey
(n = 102)
Nonresponder on
telephone survey
(n = 24)
Responder on
telephone survey
(n = 123)
Nonresponder on
paper survey
(n = 149)
Women with AD (n = 251)
Total response women with AD
(n = 201)
118 women with AD (cases)
analyzed
Excluded (n = 83)
18 nulliparous, 8 withdrawals,
4 deceased, 16 other diagnoses than
AD, 12 no specified reasons,
25 missing data
Responder on
paper survey
(n = 102)
Nonresponder on
telephone survey
(n = 50)
Responder on
telephone survey
(n = 99)
 Fig. 1. Study flow diagram. 
D
ow
nl
oa
de
d 
by
: 
R
ad
bo
ud
 U
ni
ve
rs
ite
it 
Ni
jm
eg
en
    
    
    
    
    
    
  
14
9.
12
6.
75
.1
 - 
3/
24
/2
01
6 
10
:4
5:
28
 A
M
380Dement Geriatr Cogn Disord Extra 2015;5:375–385
 DOI: 10.1159/000439043 
E X T R A
 Abheiden et al.: Hypertensive Disorders of Pregnancy Appear Not to Be Associated 
with Alzheimer’s Disease Later in Life 
www.karger.com/dee
© 2015 S. Karger AG, Basel
 Cerebral MRI 
 We examined the cerebral MRIs of the 4 women with AD and reported histories of 
preeclampsia. In  table 3 , the results of the MRIs are depicted. Three of the 4 women had MTA 
scores of 1 or 2 in either their left or their right hemisphere. The 4th woman had a score of 0. 
Two women had GCAs of 1; the other 2 women had scores of 0. The Fazekas score was 0 in 3 
women; in the 4th woman, the Fazekas score was 1. No microbleeds or infarctions were seen 
in any of the women. 
 Table 1. Baseline characteristics
Women with AD
(n = 118)
 Women without AD
(n = 139)
p
n value  n value
Age, years 113 67.1 ± 10.6 132 64.2 ± 10.3 0.035a, *
BMI 108 23.3 (5.6) 134 24.5 (6.3) 0.014b, *
Caucasian 117 108 (92.3) 130 119 (91.5) 0.83c
Smoking 114 12 (10.5) 136 16 (11.8) 0.76c
Alcohol use >1 per day 114 64 (56.1) 136 87 (64.0) 0.21c
Parity 118 2.5 ± 1.0 139 2.4 ± 0.9 0.69a
Live births 118 2.4 ± 0.9 139 2.4 ± 0.9 0.76a
Self-report
Time between survey and first child, years
117
110
31 (26.5)
41.2 ± 9.0
138
130
132 (95.7)
39.2 ± 9.8
<0.001*
0.12a
Diabetes 110 6 (5.5) 133 12 (9.0) 0.290c
Hypercholesterolemia 110 20 (18.2) 132 25 (18.9) 0.88c
Hypertension 110 20 (18.2) 134 38 (28.4) 0.06d
Myocardial infarction 111 5 (2.7) 134 1 (0.7) 0.09d
Cerebrovascular accident 112 3 (2.7) 135 8 (5.9) 0.35c
Renal disease 110 2 (1.8) 133 7 (5.3) 0.19d
Thrombosis 110 3 (2.7) 133 4 (3.0) 1.00d
Pulmonary embolism 109 1  (0.9) 134 2 (1.5) 1.00d
Brain surgery
Gestational age of firstborn, weeks
Birth weight of firstborn, g
111
66
58
0
39.3 ± 1.5
3,502 ± 656
135
125
127
1 (0.7)
39.3 ± 2.5
3,399 ± 524
1.00d
0.98a
0.30a
 All items represent the status at time of survey. Data are presented as mean ± standard deviation, n (%) 
or median (interquartile range; for BMI only). * α = 0.05, statistically significant. a Independent samples t test. 
b Mann-Whitney test. c χ2. d  Fisher’s exact test.
Women 
with AD 
(n = 104a)
Women 
without AD 
(n = 129a)
p
Hypertensive disorders of pregnancy 15 (14.4) 36 (27.9) 0.11a, b
Pregnancy-induced hypertension 11 (10.6) 32 (24.8) 0.03a, b
Preeclampsia 4 (3.8) 4 (3.1) 1.00a, b
Eclampsia 0 0 –
Data are presented as n (%). a After correction for age and BMI. b χ2.
 Table 2. Incidence of 
hypertensive disorders of 
pregnancy
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 Discussion 
 We found no difference in the reported history of hypertensive disorders of pregnancy 
between women with and without AD. This may suggest different pathophysiological 
pathways of cerebrovascular damage between AD and hypertensive disorders of pregnancy 
or longer-term reversibility of white matter lesions after hypertensive disorders of preg-
nancy. 
 In a sub-analysis, we found that the preeclampsia rates reported by women with AD were 
comparable to those of women without AD. However, women with AD reported pregnancy-
induced hypertension less frequently than women without AD. Remarkably, in women 
without AD, we encountered an incidence of pregnancy-induced hypertension of 25.9%, 
much higher than in the normal population since the prevalence of hypertensive disorders of 
pregnancy is almost 10% and pregnancy-induced hypertension is only a part of this 10%  [2, 
5, 6] . 
 In a second sub-analysis investigating if there was a difference between women with 
early-onset AD or late-onset AD, significantly more women with early-onset AD reported a 
history of hypertensive disorders of pregnancy and preeclampsia. This result is of great 
interest; early-onset AD has a different etiology (more genetic load, more aggressive cognitive 
deterioration and less mixed pathology including white matter lesions) than general AD  [43] . 
Our population contains a very large percentage of early-onset AD cases (43.2%), which is 
probably due to the fact that the Alzheimer Center of the VU University Medical Center is a 
referral center. 
 A possible explanation for the differences in percentages in both groups could be over-
reporting due to recall bias. A systematic review showed that the length of recall of hyper-
tensive disorders of pregnancy did not appear to affect recall quality (up to 30 years), though 
sensitivity was lower and less consistent for pregnancy-induced hypertension than for 
preeclampsia  [41] . The difference with our study is that our participants had an average recall 
of 40.2 years. Overreporting of pregnancy-induced hypertension is a phenomenon described 
in other studies as well; however, an explanation is lacking  [42, 44] . Furthermore, the 
difference in recall between groups could also be explained by the fact that it might be possible 
that women with AD do not remember their obstetric history as well as women without AD. 
Although the survey we used was validated  [42, 45] , it is not validated for this specific popu-
lation in women with AD. It is possible that women with AD underestimated their incidence 
of hypertensive disorders of pregnancy, and therefore the recall bias could affect both groups: 
overestimation in the controls and underestimation in the women with AD. Moreover, not all 
women answered the survey themselves, especially in the group with women with AD. We 
interviewed several partners or other family members, and we included only those who 
remembered sufficient details about the pregnancy and delivery. The difference in recall bias 
between women themselves, their partners or other family members is unknown.
Patient
1 2 3 4
MTA left hemisphere 1 2 0 0
MTA right hemisphere 0 2 0 1
GCA 1 0 1 0
Fazekas score 0 0 0 1
Microbleeds no no no no
Infarcts no no no no
 Table 3. MRI results of 4 women 
with AD and a history of 
preeclampsia
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 A further explanation for our findings suggesting overreporting could be that hyper-
tensive disorders of pregnancy are a heterogeneous syndrome, with a wide spectrum of 
clinical symptoms and differences in presentation. Some women have no complaints at all, 
others report some pain in their upper right quadrant of their abdomen or a headache, and 
some women need to go to the intensive care unit because they feel very sick. Also, the defi-
nition medical staff use for pregnancy-induced hypertension (systolic blood pressure  ≥ 140 
mm Hg and/or diastolic blood pressure  ≥ 90 mm Hg measured on two occasions 6 h apart 
 [46] ), could be stricter than the definition patients apply. 
 The clinical implications of cerebral white matter lesions in young women with a history 
of preeclampsia and eclampsia are unknown, as are the exact causes and long-term conse-
quences of previously found cognitive complaints in these women. To our knowledge, there 
are only 2 studies that report a link between preeclampsia and AD  [47, 48] . The data of the 
first study indicate that the STOX1 gene controls a conserved pathway shared between 
placenta and brain with overexpression in late-onset AD. A difference with our study is that 
the women with AD in our study who reported preeclampsia all had early-onset AD  [47] . 
 In the second study, the authors found that women with preeclampsia exhibited urine 
congophilia, whereas healthy pregnant women did not  [48] . This is a marker of protein insta-
bility and misfolding and has been used as a postmortem histological indicator of Alzheimer’s 
amyloid-β deposits in the brain of AD patients  [49, 50] . 
 The number of women with AD and a history of preeclampsia was low; therefore, the 
number of MRIs we could describe was also low. From the MRIs we could examine, 1 of the 4 
women had white matter lesions. In comparison to the studies mentioned before, the time 
frame between a hypertensive pregnancy and cerebral imaging is longer  [19–21] . In these 
studies, the MRI was performed much sooner after pre(eclampsia) than in our study, i.e. on 
average 7 years after pregnancy. To draw any conclusions about a relationship between 
hypertensive disorders of pregnancy and white matter lesions in AD, a larger study needs to 
be performed. Since earlier studies showed an association between pre(eclampsia) and white 
matter lesions on average 7 years after pregnancy  [19–21] , we expect a relationship between 
hypertensive disorders of pregnancy and white matter lesions in older age.
 Alternatively, the pathophysiological effects of hypertensive disorders of pregnancy on 
cerebrovascular function might, after all, be completely reversible over a couple of decades. 
To our knowledge, no studies have been performed to investigate white matter lesions after 
pregnancy-induced hypertension.
 The strength of our study is the novelty of the subject; to our knowledge, no other studies 
have been performed to investigate if patients with AD had a higher prevalence of hyper-
tensive disorders of pregnancy in their histories. Furthermore, we had a large response rate 
of 85.2%. One of the limitations of our study is its design (a case-control study). Preferably, we 
would have performed a prospective study. Still, we believe that for this topic an explorative 
study is currently the best approach taking into account the time limitations of a prospective 
study. Also, the number of patients with AD and a reported history of hypertensive disorders 
of pregnancy was low; we need larger samples of these subjects to assess white matter lesions 
on the MRI level to draw conclusions. Moreover, we did not achieve our power criteria; based 
on the prevalence of hypertensive disorders of pregnancy of 8.48% according to the Dutch 
Perinatal Registry, we aimed to include 233 women per group but were able to include only 
118 and 139 women in each group. In this study, we only included women with AD since the 
number of women with vascular dementia was low (n = 6), and we preferred to keep our group 
homogeneous. In future studies, it would be interesting to focus also on the women with 
vascular dementia because demented patients with a large vascular burden could be the popu-
lation in which a hypertensive disorder during pregnancy has the biggest effect.
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 Conclusion 
 No association between a reported history of hypertensive disorders of pregnancy and 
AD later in life was found in this study. In addition, we found no association between 
preeclampsia and AD. Women with AD reported pregnancy-induced hypertension less often 
than women without AD, possibly due to recall bias and lack of power. Moreover, women with 
early-onset AD reported a history of hypertensive disorders of pregnancy and preeclampsia 
significantly more often than women with late-onset AD. Future research is needed to identify 
whether there is an association between cerebrovascular damage after hypertensive disorder 
of pregnancy and early-onset and/or late-onset AD.
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